BRAIN Biotech names Sven K. Weber CEO, effective Oct. 1, 2026

Reuters2026/07/29 12:36

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

BRAIN Biotech named Dr. Sven K. Weber CEO effective Oct. 1, 2026.
Current CEO Adriaan Moelker steps down Sept. 30, 2026, then serves as senior advisor until January 2027.
Weber comes from BASF, most recently vice president running its global feed enzymes and feed performance ingredients business.
He previously led global automotive OEM business at Chemetall, headed contract research at hte, and started his career at Merck.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BRAIN Biotech AG published the original content used to generate this news brief on July 29, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

BRAIN Biotech names Sven K. Weber CEO, effective Oct. 1, 2026

You may also like

Crypto prices